Copyright: ©Author(s) 2026.
World J Clin Cases. Sep 16, 2026; 14(26): 126833
Published online Sep 16, 2026. doi: 10.12998/wjcc.126833
Published online Sep 16, 2026. doi: 10.12998/wjcc.126833
Table 1 Differential diagnosis considered during the initial evaluation of case 1
| Diagnostic possibility | Findings supporting | Findings non-supportive |
| Primary migraine | Maternal migraine history | New continuous headache, fever, confusion, pyramidal signs, MRI abnormalities |
| Sinusitis | Allergic rhinitis, frontal pain | Neurological deterioration and MRI findings |
| Viral encephalitis | Fever, vomiting, CSF lymphocytic pleocytosis and elevated protein | Negative multiplex CSF PCR panel for neurotropic viruses, characteristic ADEM MRI pattern |
| ADEM | Encephalopathy, multifocal signs, characteristic MRI | - |
| MS | Demyelinating lesions | Large poorly marginated lesions, relative periventricular sparing, monophasic pediatric clinical phenotype |
| Serum MOGAD | ADEM phenotype | Serum MOG-IgG negative by cell-based assay |
| Raised intracranial pressure/intracranial structural disease | Severe persistent headache, vomiting, and transient visual blurring could raise concern for increased intracranial pressure or an intracranial structural lesion | Normal fundoscopic examination without papilledema; normal CSF opening pressure (140 mm H2O); brain MRI demonstrated multifocal bilateral white-matter lesions consistent with ADEM rather than a focal mass lesion or structural abnormality |
Table 2 Key laboratory and diagnostic investigations
| Investigation (collection time point) | Reference range | Case 1 (day +3) | Case 2 (initial acute presentation)/case 2 (3-month readmission) |
| CSF opening pressure | 60-200 mm H2O | Normal (140 mm H2O) | Initial: Normal (130 mm H2O)/3-month: Normal (125 mm H2O) |
| CSF cells | 0-5 lymphocytes/μL | 50/μL (lymphocytic predominance) | Initial: 2 lymphocytes/μL/3-month: 1 lymphocyte/μL |
| CSF protein | 15-45 mg/dL | Elevated (75 mg/dL) | Initial: Normal (41 mg/dL)/3-month: Normal (38 mg/dL) |
| CSF glucose | 50-80 mg/dL (or ≥ 60% of serum) | Normal (55 mg/dL) | Initial: Normal (63 mg/dL)/3-month: Normal (60 mg/dL) |
| Serum glucose | 70-110 mg/dL | 89 mg/dL | 92 mg/dL |
| OCB | Negative | Negative (CSF and serum) | Not detected |
| Serum MOG-IgG (pre-treatment) | Negative (< 1:16 titer) | Negative (by live cell-based assay) | Negative (by live cell-based assay) |
| Serum AQP4-IgG (pre-treatment) | Negative (< 1:16 titer) | Negative (by live cell-based assay) | Negative (by live cell-based assay) |
| MRI brain | Normal | ADEM pattern (multifocal white matter lesions, no restricted diffusion, no contrast enhancement) | ADEM pattern (bilateral confluent white matter lesions, no restricted diffusion, no contrast enhancement) |
| MRI spine | Normal | Normal | Normal |
| EEG | Normal organization | Diffuse and focal background slowing | Not tested |
- Citation: Al-Beltagi M, Nazeer JA, Elbeltagi RM. Contrasting diagnostic challenges of headache before and after acute disseminated encephalomyelitis in children: Two case reports and review of literature. World J Clin Cases 2026; 14(26): 126833
- URL: https://www.wjgnet.com/2307-8960/full/v14/i26/126833.htm
- DOI: https://dx.doi.org/10.12998/wjcc.126833